Cargando…
Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
BACKGROUND: To investigate whether baseline serum cartilage oligomeric matrix protein (COMP), patient characteristics, traditional cardiovascular disease (CVD) risk factors and disease activity over time predict CVD, in early rheumatoid arthritis (RA). METHODS: This study included patients with earl...
Autores principales: | Rydell, Emil, Jacobsson, Lennart TH, Saxne, Tore, Turesson, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690963/ https://www.ncbi.nlm.nih.gov/pubmed/38037148 http://dx.doi.org/10.1186/s41927-023-00367-2 |
Ejemplares similares
-
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003) -
Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity
por: Saghafi, Massoud, et al.
Publicado: (2017) -
Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
por: Tseng, Susan, et al.
Publicado: (2009) -
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
por: Andersson, Maria LE, et al.
Publicado: (2006) -
Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
por: Rydell, Emil, et al.
Publicado: (2018)